References - Therapeutic Strategies in Cancer Biology and Pathology - page 223

Kumar, R., Wang, R.A., Mazumdar, A., Talukder, A.H., Mandal, M., Yang, Z., et al., 2002. A
naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm.
Nature 418, 654-657.
Kuramitsu, Y., Baron, B., Yoshino, S., Zhang, X., Tanaka, T., Yashiro, M., et al., 2010.
Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in
human scirrhous-type gastric carcinoma cells. Anticancer Res. 30, 4459-4465.
Kurisetty, V.V., Johnston, P.G., Johnston, N., Erwin, P., Crowe, P., Fernig, D.G., et al., 2008.
RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin.
Oncogene 27, 7139-7149.
Kuzontkoski. P.M., Mulligan-Kehoe, M.J., Harris, B.T., Israel, M.A. (2010). Inhibitor of DNA
binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating
matrix GLA levels. Oncogene 29, 3793-3802.
Kwok, B.H., Koh, B., Ndubuisi, M.I., Elofsson, M., Crews, C.M., 2001. The anti-inflamma-
tory natural product parthenolide from the medicinal herb Feverfew directly binds to and
inhibits IkappaB kinase. Chem. Biol. 8, 759-766.
Lai, D., Chen, Y., Wang, F., Jiang, L., Wei, C., 2012. LKB1 controls the pluripotent state of
human embryonic stem cells. Cell Program 14, 164-170.
Lai, Z.C., Wei, X.M., Shimizu, T., Ramos, E., Rohrbaugh, M., Nikolaidis, N., et al., 2005. Control
of cell proliferation and apoptosis by Mob as tumor suppressor, Mats. Cell 120, 675-685.
Lakshmi, M.S., Sherbet, G.V., 1997. Expression of transmembrane glycoprotein CD44 and
metastasis associated gene 18A2/mts1 gene in B16 murine melanoma. Anticancer Res.
17, 3451-3456.
Lakshmikuttyamma, A., Takahashi, N., Pastural, E.,Torlakovic, E., Amin, H.M., Garcia-
Manero, G., et al., (2009). RIZ1 is potential CML tumor suppressor that is down-regu-
lated during disease progression. J Hematol Oncol. 2, art. no. 28.
Lal, A., Thomas, M.P., Altschuler, G., Navarro, F., O'Day, E., Li, X.L., et al., 2011. Capture
of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of
growth factor signaling. Plos Genet. 7, e1002363.
Lallemand, D., Curto, M., Saotome, I., Giovannini, M., McClatchey, A.I., 2003. NF2 defi-
ciency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes
Develop. 17, 1090-1100.
Lambert, K.E., Huang, H., Mythreye, K., Blobe, G.C., 2011. The type III transforming growth
factor-beta receptor inhibits proliferation, migration, and adhesion in human myeloma
cells. Mol. Biol. Cell 22, 1463-1472.
Laprise, P., Langlois, M.J., Boucher, M.J., Jobin, C., Rivard, N., 2004. Down-regulation of
MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating
intestinal epithelial cells. J. Cell. Physiol. 199, 32-59.
Lavergne, E., Hendaoui, I., Coulouarn, C., Ribault, C., Leseur, J., Eliat, P.A., et al., 2011.
Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and
tumor growth in cells carrying active beta-catenin. Oncogene 30, 423-433.
Lazennec, G., Bresson, D., Lucas, A., chauveau, C., Vignon, F., 2001. ER beta inhibits prolif-
eration and invasion of breast cancer cells. Endocrinology 142, 4120-4130.
Le, N.T.V., Richardson, D.R., 2004. Iron chelators with high antiproliferative activity up-regu-
late the expression of a growth inhibitory and metastasis suppressor gene: a link between
iron metabolism and proliferation. Blood 104, 2967-2975.
Lee, C.W., Wong, L.L.Y., Tse, Y.E.T., Liu, H.F., Leong, V.Y.L., Lee, J.M.F., et al., 2012.
AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver
cancer cells. Cancer Res. 72, 4394-4404.